 Eric Simoes
Concepts (432)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiratory Syncytial Virus Infections | 39 | 2018 | 99 | 6.100 |
Why?
| | Respiratory Syncytial Viruses | 18 | 2017 | 48 | 1.960 |
Why?
| | Respiratory Syncytial Virus, Human | 12 | 2018 | 61 | 1.410 |
Why?
| | Hospitalization | 19 | 2021 | 1784 | 1.080 |
Why?
| | Antibodies, Monoclonal | 9 | 2007 | 1285 | 0.930 |
Why?
| | Antibodies, Viral | 15 | 2018 | 542 | 0.840 |
Why?
| | Immunoglobulins, Intravenous | 9 | 2002 | 128 | 0.830 |
Why?
| | Respiratory Tract Infections | 11 | 2017 | 331 | 0.820 |
Why?
| | Macaca radiata | 8 | 2003 | 16 | 0.810 |
Why?
| | Otoscopes | 1 | 2021 | 4 | 0.790 |
Why?
| | Seasons | 9 | 2021 | 461 | 0.720 |
Why?
| | Pneumococcal Vaccines | 2 | 2021 | 140 | 0.720 |
Why?
| | Infant | 56 | 2018 | 8293 | 0.680 |
Why?
| | Antiviral Agents | 5 | 2007 | 654 | 0.670 |
Why?
| | Respiratory Syncytial Virus Vaccines | 4 | 2013 | 24 | 0.660 |
Why?
| | Infant, Premature | 10 | 2007 | 480 | 0.570 |
Why?
| | Poliovirus | 5 | 2001 | 78 | 0.530 |
Why?
| | Bronchiolitis, Viral | 3 | 2013 | 10 | 0.450 |
Why?
| | Infant, Newborn | 30 | 2018 | 5255 | 0.450 |
Why?
| | Child, Preschool | 40 | 2017 | 9491 | 0.450 |
Why?
| | Pneumonia | 10 | 2011 | 592 | 0.440 |
Why?
| | Infant, Premature, Diseases | 4 | 2002 | 93 | 0.440 |
Why?
| | Palivizumab | 8 | 2007 | 13 | 0.440 |
Why?
| | Developing Countries | 9 | 2017 | 255 | 0.420 |
Why?
| | Immunoglobulins | 3 | 2002 | 154 | 0.400 |
Why?
| | Viral Vaccines | 4 | 2005 | 90 | 0.400 |
Why?
| | Respiratory Sounds | 4 | 2013 | 119 | 0.370 |
Why?
| | Bronchiolitis | 6 | 1999 | 83 | 0.360 |
Why?
| | Virus Diseases | 3 | 2015 | 198 | 0.360 |
Why?
| | Pneumococcal Infections | 2 | 2008 | 96 | 0.340 |
Why?
| | Disease Outbreaks | 4 | 2021 | 322 | 0.330 |
Why?
| | Heart Defects, Congenital | 6 | 2005 | 703 | 0.330 |
Why?
| | Humans | 88 | 2021 | 118983 | 0.320 |
Why?
| | Immunization, Passive | 4 | 2002 | 81 | 0.320 |
Why?
| | Antibodies, Monoclonal, Humanized | 9 | 2007 | 667 | 0.320 |
Why?
| | Carotid Artery Thrombosis | 1 | 2007 | 8 | 0.310 |
Why?
| | Cavernous Sinus Thrombosis | 1 | 2007 | 9 | 0.310 |
Why?
| | Mucormycosis | 1 | 2007 | 20 | 0.300 |
Why?
| | Philippines | 7 | 2021 | 55 | 0.300 |
Why?
| | Paranasal Sinus Diseases | 1 | 2007 | 14 | 0.300 |
Why?
| | Carotid Artery, Internal | 1 | 2007 | 34 | 0.300 |
Why?
| | Spinal Cord | 2 | 2001 | 367 | 0.300 |
Why?
| | Orbital Diseases | 1 | 2007 | 26 | 0.300 |
Why?
| | Influenza, Human | 3 | 2021 | 554 | 0.290 |
Why?
| | Poliovirus Vaccine, Inactivated | 4 | 1988 | 25 | 0.290 |
Why?
| | Antifungal Agents | 1 | 2007 | 134 | 0.280 |
Why?
| | Vaccines, Attenuated | 4 | 2001 | 114 | 0.280 |
Why?
| | Triazoles | 1 | 2007 | 134 | 0.280 |
Why?
| | Child | 23 | 2021 | 19129 | 0.270 |
Why?
| | Sex Work | 3 | 1993 | 17 | 0.270 |
Why?
| | Incidence | 9 | 2017 | 2424 | 0.270 |
Why?
| | Bronchopulmonary Dysplasia | 6 | 1998 | 325 | 0.260 |
Why?
| | Pneumonia, Viral | 5 | 2000 | 348 | 0.260 |
Why?
| | Prospective Studies | 15 | 2015 | 6473 | 0.260 |
Why?
| | Child, Hospitalized | 1 | 2005 | 43 | 0.250 |
Why?
| | Community-Acquired Infections | 3 | 2015 | 143 | 0.250 |
Why?
| | India | 10 | 2018 | 141 | 0.230 |
Why?
| | Metapneumovirus | 2 | 2013 | 12 | 0.230 |
Why?
| | Leukotriene Antagonists | 1 | 2003 | 40 | 0.220 |
Why?
| | Poliomyelitis | 2 | 2001 | 30 | 0.210 |
Why?
| | Acetates | 1 | 2003 | 98 | 0.210 |
Why?
| | Bronchial Provocation Tests | 1 | 2002 | 54 | 0.210 |
Why?
| | Population Surveillance | 2 | 2005 | 413 | 0.210 |
Why?
| | Severity of Illness Index | 6 | 2008 | 2674 | 0.210 |
Why?
| | Developed Countries | 1 | 2002 | 32 | 0.210 |
Why?
| | Quinolines | 1 | 2003 | 128 | 0.210 |
Why?
| | Length of Stay | 4 | 2005 | 1031 | 0.210 |
Why?
| | Altitude | 1 | 2006 | 422 | 0.210 |
Why?
| | Risk Factors | 16 | 2017 | 9001 | 0.210 |
Why?
| | Disease Models, Animal | 5 | 2003 | 3730 | 0.210 |
Why?
| | Female | 38 | 2018 | 61574 | 0.210 |
Why?
| | Cross Infection | 2 | 2013 | 205 | 0.200 |
Why?
| | Poliovirus Vaccine, Oral | 1 | 2001 | 22 | 0.200 |
Why?
| | Measles | 1 | 2021 | 39 | 0.200 |
Why?
| | Otoscopy | 1 | 2021 | 8 | 0.200 |
Why?
| | Child Health Services | 1 | 2003 | 177 | 0.200 |
Why?
| | Mothers | 2 | 2005 | 682 | 0.200 |
Why?
| | Peripheral Nerves | 1 | 2001 | 65 | 0.190 |
Why?
| | Hospital Charges | 1 | 2000 | 42 | 0.190 |
Why?
| | Denmark | 3 | 2009 | 41 | 0.190 |
Why?
| | Male | 34 | 2015 | 57808 | 0.180 |
Why?
| | Environmental Exposure | 1 | 2003 | 405 | 0.180 |
Why?
| | Diphtheria Toxoid | 3 | 1988 | 12 | 0.170 |
Why?
| | Asthma | 3 | 2001 | 2157 | 0.170 |
Why?
| | Pertussis Vaccine | 3 | 1988 | 21 | 0.170 |
Why?
| | Tetanus Toxoid | 3 | 1988 | 37 | 0.170 |
Why?
| | Anxiety | 1 | 2005 | 845 | 0.170 |
Why?
| | Caregivers | 1 | 2005 | 709 | 0.170 |
Why?
| | Referral and Consultation | 1 | 2003 | 648 | 0.170 |
Why?
| | Colorado | 4 | 2021 | 4196 | 0.160 |
Why?
| | Parvovirus B19, Human | 1 | 2018 | 3 | 0.160 |
Why?
| | Parvoviridae Infections | 1 | 2018 | 11 | 0.160 |
Why?
| | HN Protein | 1 | 1998 | 5 | 0.160 |
Why?
| | Cost of Illness | 1 | 2000 | 258 | 0.160 |
Why?
| | Virus Replication | 4 | 2003 | 405 | 0.160 |
Why?
| | Respiratory Tract Diseases | 1 | 1999 | 143 | 0.160 |
Why?
| | Measles Vaccine | 2 | 1988 | 17 | 0.160 |
Why?
| | Viral Proteins | 2 | 1998 | 296 | 0.160 |
Why?
| | Rickets | 1 | 1997 | 6 | 0.150 |
Why?
| | Stress, Psychological | 1 | 2005 | 972 | 0.150 |
Why?
| | RNA, Viral | 3 | 2001 | 572 | 0.150 |
Why?
| | Ventilator Weaning | 1 | 1997 | 33 | 0.150 |
Why?
| | Lung Diseases | 1 | 2003 | 718 | 0.150 |
Why?
| | Air | 1 | 1997 | 48 | 0.150 |
Why?
| | Education, Nursing, Continuing | 1 | 1997 | 40 | 0.140 |
Why?
| | Postpartum Period | 1 | 2018 | 271 | 0.140 |
Why?
| | Adult | 12 | 2021 | 31515 | 0.130 |
Why?
| | Acquired Immunodeficiency Syndrome | 2 | 1987 | 224 | 0.130 |
Why?
| | Neutralization Tests | 3 | 2001 | 66 | 0.130 |
Why?
| | Pharyngeal Diseases | 1 | 1995 | 15 | 0.130 |
Why?
| | In Situ Hybridization | 3 | 2001 | 311 | 0.130 |
Why?
| | Haemophilus Infections | 1 | 1995 | 31 | 0.130 |
Why?
| | Mouth | 1 | 1995 | 74 | 0.130 |
Why?
| | Jugular Veins | 1 | 1995 | 47 | 0.130 |
Why?
| | Double-Blind Method | 8 | 2007 | 1687 | 0.130 |
Why?
| | Cerebral Aqueduct | 1 | 1994 | 3 | 0.120 |
Why?
| | Abscess | 1 | 1995 | 75 | 0.120 |
Why?
| | Infectious Mononucleosis | 1 | 1994 | 9 | 0.120 |
Why?
| | Gestational Age | 3 | 2005 | 765 | 0.120 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2018 | 296 | 0.120 |
Why?
| | Otitis Media | 1 | 1996 | 146 | 0.120 |
Why?
| | Respirovirus Infections | 2 | 1993 | 21 | 0.120 |
Why?
| | HIV Infections | 3 | 2018 | 2459 | 0.120 |
Why?
| | Nucleoproteins | 1 | 2013 | 28 | 0.120 |
Why?
| | Human bocavirus | 1 | 2013 | 1 | 0.120 |
Why?
| | HIV Antibodies | 1 | 1993 | 50 | 0.120 |
Why?
| | Triplets | 1 | 1993 | 5 | 0.120 |
Why?
| | Models, Statistical | 1 | 2017 | 636 | 0.110 |
Why?
| | Hydrocephalus | 1 | 1994 | 81 | 0.110 |
Why?
| | Primary Health Care | 1 | 2003 | 1560 | 0.110 |
Why?
| | Oropharynx | 1 | 2013 | 41 | 0.110 |
Why?
| | Streptococcal Infections | 1 | 1995 | 141 | 0.110 |
Why?
| | Disease Management | 1 | 1997 | 571 | 0.110 |
Why?
| | Cohort Studies | 4 | 2018 | 5115 | 0.110 |
Why?
| | Pediatric Nursing | 1 | 1992 | 40 | 0.110 |
Why?
| | Community Health Workers | 1 | 1992 | 49 | 0.110 |
Why?
| | Vaccines, Inactivated | 2 | 2003 | 68 | 0.110 |
Why?
| | Encephalitis | 1 | 1994 | 129 | 0.110 |
Why?
| | Case-Control Studies | 5 | 2018 | 3171 | 0.100 |
Why?
| | Diseases in Twins | 1 | 1993 | 181 | 0.100 |
Why?
| | Respiratory Physiological Phenomena | 1 | 1991 | 31 | 0.100 |
Why?
| | Respiratory Function Tests | 3 | 2002 | 526 | 0.100 |
Why?
| | Europe | 2 | 2003 | 356 | 0.100 |
Why?
| | Thrombosis | 1 | 1995 | 309 | 0.100 |
Why?
| | Pneumonia, Bacterial | 2 | 2009 | 110 | 0.100 |
Why?
| | Breast Feeding | 2 | 2003 | 386 | 0.100 |
Why?
| | Ulnar Nerve | 2 | 2001 | 17 | 0.100 |
Why?
| | Age Distribution | 4 | 2007 | 362 | 0.100 |
Why?
| | Genes, Viral | 1 | 1991 | 93 | 0.100 |
Why?
| | Socioeconomic Factors | 2 | 2006 | 1129 | 0.090 |
Why?
| | Time Factors | 7 | 2018 | 6414 | 0.090 |
Why?
| | Sequence Analysis, DNA | 1 | 2013 | 755 | 0.090 |
Why?
| | Adolescent | 4 | 2021 | 18479 | 0.090 |
Why?
| | Clinical Competence | 1 | 1997 | 951 | 0.090 |
Why?
| | Lung | 2 | 2001 | 3664 | 0.090 |
Why?
| | Logistic Models | 4 | 2009 | 1901 | 0.090 |
Why?
| | Algorithms | 3 | 2009 | 1541 | 0.080 |
Why?
| | Protein Biosynthesis | 1 | 1991 | 397 | 0.080 |
Why?
| | Sensitivity and Specificity | 5 | 2007 | 1795 | 0.080 |
Why?
| | Longitudinal Studies | 4 | 2018 | 2513 | 0.080 |
Why?
| | Animals | 10 | 2004 | 33390 | 0.080 |
Why?
| | Global Health | 2 | 2017 | 310 | 0.080 |
Why?
| | Single-Blind Method | 3 | 1998 | 269 | 0.080 |
Why?
| | Young Adult | 2 | 2021 | 10795 | 0.080 |
Why?
| | Maternal-Fetal Exchange | 1 | 2009 | 157 | 0.080 |
Why?
| | HIV-1 | 1 | 1993 | 776 | 0.080 |
Why?
| | Respiration | 3 | 1997 | 183 | 0.080 |
Why?
| | Mucor | 1 | 2007 | 7 | 0.080 |
Why?
| | Ethiopia | 2 | 1997 | 35 | 0.080 |
Why?
| | United States | 5 | 2007 | 12554 | 0.080 |
Why?
| | Weather | 1 | 2007 | 24 | 0.070 |
Why?
| | Debridement | 1 | 2007 | 79 | 0.070 |
Why?
| | Central Nervous System Bacterial Infections | 1 | 2006 | 5 | 0.070 |
Why?
| | Reference Values | 2 | 2007 | 775 | 0.070 |
Why?
| | Meningitis, Bacterial | 1 | 2007 | 51 | 0.070 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2007 | 39 | 0.070 |
Why?
| | Probability | 1 | 2007 | 305 | 0.070 |
Why?
| | Cell Line | 3 | 2004 | 2708 | 0.070 |
Why?
| | Predictive Value of Tests | 5 | 2009 | 1868 | 0.070 |
Why?
| | Deltaretrovirus | 1 | 1985 | 12 | 0.070 |
Why?
| | Secondary Prevention | 1 | 2007 | 227 | 0.070 |
Why?
| | Convalescence | 1 | 2005 | 15 | 0.070 |
Why?
| | DNA, Bacterial | 1 | 2007 | 314 | 0.070 |
Why?
| | Biomedical Research | 1 | 2011 | 612 | 0.070 |
Why?
| | Pregnancy | 3 | 2018 | 5692 | 0.070 |
Why?
| | Athetosis | 1 | 2005 | 8 | 0.060 |
Why?
| | Drug Administration Schedule | 1 | 2007 | 736 | 0.060 |
Why?
| | Chorea | 1 | 2005 | 12 | 0.060 |
Why?
| | Cyanosis | 2 | 2009 | 17 | 0.060 |
Why?
| | Antibodies, Bacterial | 2 | 2000 | 126 | 0.060 |
Why?
| | Immunoglobulin G | 2 | 2000 | 788 | 0.060 |
Why?
| | Paramyxoviridae | 1 | 2004 | 2 | 0.060 |
Why?
| | Paramyxoviridae Infections | 1 | 2004 | 10 | 0.060 |
Why?
| | Blood Donors | 1 | 1985 | 109 | 0.060 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2007 | 770 | 0.060 |
Why?
| | Sinusitis | 2 | 1999 | 175 | 0.060 |
Why?
| | Maxillary Sinus | 1 | 2004 | 13 | 0.060 |
Why?
| | Maxillary Sinusitis | 1 | 2004 | 8 | 0.060 |
Why?
| | Family Health | 1 | 2005 | 201 | 0.060 |
Why?
| | Orthomyxoviridae | 1 | 2004 | 37 | 0.060 |
Why?
| | Hypothermia, Induced | 1 | 2005 | 68 | 0.060 |
Why?
| | Orthomyxoviridae Infections | 1 | 2004 | 53 | 0.060 |
Why?
| | Africa South of the Sahara | 1 | 2003 | 37 | 0.060 |
Why?
| | Data Interpretation, Statistical | 1 | 2005 | 336 | 0.060 |
Why?
| | U937 Cells | 1 | 2003 | 26 | 0.060 |
Why?
| | Equipment and Supplies | 1 | 2003 | 39 | 0.060 |
Why?
| | Multivariate Analysis | 1 | 2007 | 1474 | 0.060 |
Why?
| | Nasal Mucosa | 1 | 2004 | 97 | 0.060 |
Why?
| | Acute Disease | 3 | 2013 | 941 | 0.060 |
Why?
| | Spain | 1 | 2003 | 34 | 0.060 |
Why?
| | Disease Susceptibility | 1 | 2005 | 331 | 0.060 |
Why?
| | Diphtheria-Tetanus-Pertussis Vaccine | 3 | 1988 | 25 | 0.060 |
Why?
| | Cyclopropanes | 1 | 2003 | 80 | 0.060 |
Why?
| | Steroids | 2 | 2001 | 153 | 0.060 |
Why?
| | Cell Count | 2 | 2004 | 315 | 0.060 |
Why?
| | Malnutrition | 1 | 2003 | 66 | 0.060 |
Why?
| | Blood Transfusion | 1 | 1985 | 306 | 0.060 |
Why?
| | Intensive Care Units, Neonatal | 2 | 1997 | 178 | 0.060 |
Why?
| | Demography | 1 | 2003 | 274 | 0.060 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2007 | 1947 | 0.050 |
Why?
| | South Africa | 2 | 2018 | 163 | 0.050 |
Why?
| | Odds Ratio | 2 | 1997 | 996 | 0.050 |
Why?
| | Climate | 1 | 2003 | 91 | 0.050 |
Why?
| | Rhinitis | 1 | 2004 | 129 | 0.050 |
Why?
| | Geography | 1 | 2003 | 190 | 0.050 |
Why?
| | Sulfides | 1 | 2003 | 96 | 0.050 |
Why?
| | Japan | 1 | 2002 | 97 | 0.050 |
Why?
| | Treatment Outcome | 7 | 2007 | 9343 | 0.050 |
Why?
| | Phylogeny | 2 | 2018 | 816 | 0.050 |
Why?
| | Morbidity | 1 | 2003 | 296 | 0.050 |
Why?
| | Drug Combinations | 3 | 1988 | 291 | 0.050 |
Why?
| | Formaldehyde | 1 | 2001 | 50 | 0.050 |
Why?
| | Follow-Up Studies | 3 | 2007 | 4596 | 0.050 |
Why?
| | Vaccines, Synthetic | 1 | 2002 | 128 | 0.050 |
Why?
| | Vaccines, Subunit | 1 | 2001 | 42 | 0.050 |
Why?
| | Body Weight | 1 | 1986 | 934 | 0.050 |
Why?
| | Virus Shedding | 1 | 2001 | 41 | 0.050 |
Why?
| | Administration, Inhalation | 2 | 2001 | 656 | 0.050 |
Why?
| | Autopsy | 1 | 2001 | 89 | 0.050 |
Why?
| | Canada | 1 | 2002 | 340 | 0.050 |
Why?
| | Models, Immunological | 1 | 2001 | 94 | 0.050 |
Why?
| | Mortality | 1 | 2003 | 299 | 0.050 |
Why?
| | Oxygen | 1 | 2005 | 854 | 0.050 |
Why?
| | Macaca | 1 | 1980 | 54 | 0.050 |
Why?
| | Serum Albumin | 1 | 2001 | 146 | 0.050 |
Why?
| | Health Services Research | 1 | 2003 | 385 | 0.050 |
Why?
| | Viremia | 1 | 2001 | 132 | 0.050 |
Why?
| | Nerve Fibers, Myelinated | 1 | 1980 | 46 | 0.050 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2000 | 827 | 0.050 |
Why?
| | Bacteria | 1 | 2007 | 757 | 0.050 |
Why?
| | Cross-Sectional Studies | 3 | 2018 | 4552 | 0.050 |
Why?
| | Nasopharynx | 2 | 1998 | 64 | 0.050 |
Why?
| | Influenza B virus | 2 | 2004 | 33 | 0.050 |
Why?
| | Neuroglia | 1 | 2001 | 157 | 0.050 |
Why?
| | Intensive Care Units, Pediatric | 2 | 1998 | 157 | 0.050 |
Why?
| | Anti-Inflammatory Agents | 2 | 2001 | 465 | 0.050 |
Why?
| | Cardiac Surgical Procedures | 1 | 2005 | 461 | 0.050 |
Why?
| | Wrist | 1 | 1980 | 51 | 0.050 |
Why?
| | Tobacco Smoke Pollution | 1 | 2003 | 233 | 0.050 |
Why?
| | BCG Vaccine | 1 | 1999 | 25 | 0.040 |
Why?
| | Influenza A virus | 2 | 2004 | 90 | 0.040 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 2000 | 113 | 0.040 |
Why?
| | Injections, Intravenous | 1 | 1999 | 210 | 0.040 |
Why?
| | Hand | 1 | 1980 | 137 | 0.040 |
Why?
| | Fever | 2 | 2018 | 283 | 0.040 |
Why?
| | Patient Discharge | 1 | 2005 | 794 | 0.040 |
Why?
| | Hospital Mortality | 2 | 2017 | 814 | 0.040 |
Why?
| | Intensive Care Units | 1 | 2003 | 635 | 0.040 |
Why?
| | Antigens, Viral | 1 | 1999 | 181 | 0.040 |
Why?
| | Parvovirus | 1 | 2018 | 13 | 0.040 |
Why?
| | Vaccination | 2 | 2001 | 1222 | 0.040 |
Why?
| | Sex Factors | 1 | 2003 | 1781 | 0.040 |
Why?
| | Risk Assessment | 1 | 2007 | 3057 | 0.040 |
Why?
| | Vaccines, Combined | 2 | 1988 | 46 | 0.040 |
Why?
| | Age Factors | 3 | 2006 | 2995 | 0.040 |
Why?
| | Fluorescent Antibody Technique | 1 | 1998 | 410 | 0.040 |
Why?
| | Research | 1 | 2001 | 411 | 0.040 |
Why?
| | Nutrition Disorders | 1 | 1997 | 23 | 0.040 |
Why?
| | Viral Envelope Proteins | 1 | 1998 | 80 | 0.040 |
Why?
| | Health Services Accessibility | 1 | 2003 | 781 | 0.040 |
Why?
| | Child Nutrition Disorders | 1 | 1997 | 16 | 0.040 |
Why?
| | Practice Guidelines as Topic | 2 | 2009 | 1440 | 0.040 |
Why?
| | World Health Organization | 2 | 2008 | 107 | 0.040 |
Why?
| | Cost-Benefit Analysis | 1 | 2000 | 554 | 0.040 |
Why?
| | Bacterial Infections | 2 | 2007 | 227 | 0.040 |
Why?
| | Pediatrics | 2 | 1997 | 985 | 0.040 |
Why?
| | Animals, Newborn | 1 | 1999 | 806 | 0.040 |
Why?
| | Nursing Assessment | 1 | 1997 | 46 | 0.040 |
Why?
| | Birth Weight | 2 | 1993 | 465 | 0.040 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 1999 | 613 | 0.040 |
Why?
| | Prevalence | 1 | 2003 | 2326 | 0.040 |
Why?
| | Pulmonary Alveoli | 1 | 1999 | 384 | 0.040 |
Why?
| | Dehydration | 1 | 1997 | 61 | 0.040 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 1997 | 98 | 0.030 |
Why?
| | Macrophages, Alveolar | 1 | 1999 | 359 | 0.030 |
Why?
| | DNA, Viral | 1 | 2018 | 356 | 0.030 |
Why?
| | Aged | 3 | 2013 | 19657 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 1 | 2007 | 3174 | 0.030 |
Why?
| | Oxygen Inhalation Therapy | 1 | 1997 | 124 | 0.030 |
Why?
| | Bangladesh | 1 | 2015 | 39 | 0.030 |
Why?
| | Comorbidity | 1 | 2000 | 1526 | 0.030 |
Why?
| | Lung Abscess | 1 | 1995 | 7 | 0.030 |
Why?
| | Nasal Cavity | 1 | 2015 | 47 | 0.030 |
Why?
| | Epidemiological Monitoring | 1 | 2015 | 49 | 0.030 |
Why?
| | Blood | 1 | 2015 | 100 | 0.030 |
Why?
| | Cerebrospinal Fluid | 1 | 2015 | 93 | 0.030 |
Why?
| | Nutritional Status | 1 | 1997 | 300 | 0.030 |
Why?
| | Prognosis | 1 | 2003 | 3443 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 1997 | 586 | 0.030 |
Why?
| | Eating | 2 | 1999 | 369 | 0.030 |
Why?
| | Ventriculoperitoneal Shunt | 1 | 1994 | 33 | 0.030 |
Why?
| | Counseling | 1 | 1997 | 353 | 0.030 |
Why?
| | Opportunistic Infections | 1 | 1993 | 42 | 0.030 |
Why?
| | Ribavirin | 1 | 1994 | 88 | 0.030 |
Why?
| | Herpesvirus 4, Human | 1 | 1994 | 126 | 0.030 |
Why?
| | Constriction, Pathologic | 1 | 1994 | 203 | 0.030 |
Why?
| | Respiration, Artificial | 1 | 1997 | 545 | 0.030 |
Why?
| | Neurons | 1 | 2001 | 1345 | 0.030 |
Why?
| | Influenza Vaccines | 1 | 1998 | 500 | 0.030 |
Why?
| | Crowding | 1 | 1993 | 38 | 0.030 |
Why?
| | Retrospective Studies | 5 | 2008 | 12977 | 0.030 |
Why?
| | Hospitals, University | 1 | 1993 | 172 | 0.030 |
Why?
| | Sexual Partners | 1 | 1993 | 159 | 0.030 |
Why?
| | Methods | 1 | 1991 | 67 | 0.030 |
Why?
| | Rural Population | 1 | 2015 | 452 | 0.030 |
Why?
| | Radiography | 3 | 2008 | 861 | 0.030 |
Why?
| | RNA, Messenger | 1 | 1999 | 2657 | 0.030 |
Why?
| | Cell Transformation, Viral | 1 | 1991 | 22 | 0.020 |
Why?
| | Immunocompromised Host | 1 | 2013 | 200 | 0.020 |
Why?
| | Psychomotor Agitation | 1 | 1991 | 71 | 0.020 |
Why?
| | Inflammation | 1 | 2001 | 2566 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 982 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 1 | 1991 | 364 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 1991 | 546 | 0.020 |
Why?
| | Rural Health | 1 | 2009 | 72 | 0.020 |
Why?
| | Typhoid-Paratyphoid Vaccines | 1 | 1989 | 4 | 0.020 |
Why?
| | Sexual Behavior | 1 | 1993 | 437 | 0.020 |
Why?
| | Hospitals, Pediatric | 1 | 1993 | 505 | 0.020 |
Why?
| | HeLa Cells | 1 | 1991 | 583 | 0.020 |
Why?
| | Salmonella typhi | 1 | 1989 | 12 | 0.020 |
Why?
| | Typhoid Fever | 1 | 1989 | 10 | 0.020 |
Why?
| | Transfection | 1 | 1991 | 890 | 0.020 |
Why?
| | Measles virus | 1 | 1988 | 11 | 0.020 |
Why?
| | Genetic Variation | 1 | 2013 | 926 | 0.020 |
Why?
| | Middle Aged | 2 | 2001 | 27623 | 0.020 |
Why?
| | Nucleic Acid Conformation | 1 | 1991 | 670 | 0.020 |
Why?
| | Meteorological Concepts | 1 | 2007 | 5 | 0.020 |
Why?
| | Buchnera | 1 | 2007 | 1 | 0.020 |
Why?
| | Kinetics | 1 | 1991 | 1625 | 0.020 |
Why?
| | Half-Life | 2 | 1999 | 147 | 0.020 |
Why?
| | Humidity | 1 | 2007 | 45 | 0.020 |
Why?
| | Base Sequence | 1 | 1991 | 2160 | 0.020 |
Why?
| | Anti-Bacterial Agents | 3 | 2007 | 1510 | 0.020 |
Why?
| | Bacteriological Techniques | 1 | 2007 | 66 | 0.020 |
Why?
| | Hypersensitivity, Immediate | 1 | 2006 | 59 | 0.020 |
Why?
| | Genome, Bacterial | 1 | 2007 | 109 | 0.020 |
Why?
| | Weaning | 1 | 1986 | 57 | 0.020 |
Why?
| | Sleep | 1 | 1991 | 660 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 1991 | 2873 | 0.020 |
Why?
| | Models, Molecular | 1 | 1991 | 1435 | 0.020 |
Why?
| | Evaluation Studies as Topic | 1 | 1985 | 182 | 0.020 |
Why?
| | Chronic Disease | 2 | 2004 | 1637 | 0.020 |
Why?
| | Antibody Formation | 1 | 1987 | 276 | 0.020 |
Why?
| | Mozambique | 1 | 2005 | 5 | 0.020 |
Why?
| | Infant, Low Birth Weight | 1 | 1986 | 125 | 0.020 |
Why?
| | Nigeria | 1 | 2005 | 15 | 0.020 |
Why?
| | Indonesia | 1 | 2005 | 20 | 0.020 |
Why?
| | Acid-Base Equilibrium | 1 | 2005 | 29 | 0.020 |
Why?
| | Parainfluenza Virus 1, Human | 1 | 2004 | 2 | 0.020 |
Why?
| | Parainfluenza Virus 2, Human | 1 | 2004 | 3 | 0.020 |
Why?
| | Parainfluenza Virus 3, Human | 1 | 2004 | 5 | 0.020 |
Why?
| | Nasal Lavage Fluid | 1 | 2004 | 11 | 0.020 |
Why?
| | Virus Cultivation | 1 | 2004 | 25 | 0.020 |
Why?
| | Adenoviruses, Human | 1 | 2004 | 24 | 0.020 |
Why?
| | Exocrine Glands | 1 | 2004 | 5 | 0.020 |
Why?
| | Basement Membrane | 1 | 2004 | 32 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2007 | 1295 | 0.020 |
Why?
| | Immunization Schedule | 1 | 1985 | 188 | 0.020 |
Why?
| | Temperature | 1 | 2007 | 622 | 0.020 |
Why?
| | Ultraviolet Rays | 1 | 2007 | 381 | 0.020 |
Why?
| | Body Temperature | 1 | 2005 | 215 | 0.020 |
Why?
| | Risk | 1 | 1987 | 854 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2007 | 1012 | 0.010 |
Why?
| | Plasma Cells | 1 | 2004 | 59 | 0.010 |
Why?
| | Rectum | 1 | 2005 | 157 | 0.010 |
Why?
| | Immunization | 1 | 1986 | 412 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2005 | 536 | 0.010 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 1999 | 3361 | 0.010 |
Why?
| | Cardiopulmonary Bypass | 1 | 2005 | 203 | 0.010 |
Why?
| | Survival Rate | 1 | 2007 | 1720 | 0.010 |
Why?
| | Carbon Dioxide | 1 | 2005 | 230 | 0.010 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2008 | 1244 | 0.010 |
Why?
| | Esophagus | 1 | 2005 | 237 | 0.010 |
Why?
| | Escherichia coli | 1 | 2007 | 758 | 0.010 |
Why?
| | Phenotype | 1 | 1991 | 3004 | 0.010 |
Why?
| | Lymphocytes | 1 | 2004 | 347 | 0.010 |
Why?
| | Eosinophils | 1 | 2004 | 282 | 0.010 |
Why?
| | Metacarpophalangeal Joint | 1 | 1980 | 11 | 0.010 |
Why?
| | Biopsy | 1 | 2004 | 1079 | 0.010 |
Why?
| | Polysaccharides, Bacterial | 1 | 2000 | 69 | 0.010 |
Why?
| | Medical Records | 1 | 2000 | 163 | 0.010 |
Why?
| | Nasal Decongestants | 1 | 1999 | 9 | 0.010 |
Why?
| | Placebos | 1 | 1999 | 202 | 0.010 |
Why?
| | Glutamate Decarboxylase | 1 | 1999 | 159 | 0.010 |
Why?
| | Insulin Antibodies | 1 | 1999 | 101 | 0.010 |
Why?
| | Otorhinolaryngologic Surgical Procedures | 1 | 1999 | 39 | 0.010 |
Why?
| | C-Peptide | 1 | 1999 | 139 | 0.010 |
Why?
| | Injections, Intramuscular | 1 | 1999 | 116 | 0.010 |
Why?
| | Bacteremia | 1 | 2000 | 161 | 0.010 |
Why?
| | Radiography, Thoracic | 1 | 1997 | 164 | 0.010 |
Why?
| | Recurrence | 1 | 1999 | 975 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 1999 | 1167 | 0.010 |
Why?
| | Physical Examination | 1 | 1997 | 243 | 0.010 |
Why?
| | Therapeutic Equivalency | 1 | 1995 | 18 | 0.010 |
Why?
| | Patient Selection | 1 | 1999 | 675 | 0.010 |
Why?
| | Evidence-Based Medicine | 1 | 1999 | 693 | 0.010 |
Why?
| | Islets of Langerhans | 1 | 1999 | 739 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 1997 | 1384 | 0.010 |
Why?
| | Autoantibodies | 1 | 1999 | 1335 | 0.010 |
Why?
| | Pleura | 1 | 1991 | 18 | 0.010 |
Why?
| | Tropical Climate | 1 | 1991 | 19 | 0.010 |
Why?
| | Acetaminophen | 1 | 1994 | 244 | 0.010 |
Why?
| | Pharynx | 1 | 1991 | 53 | 0.010 |
Why?
| | Clinical Protocols | 1 | 1992 | 238 | 0.010 |
Why?
| | Blood Glucose | 1 | 1999 | 1946 | 0.010 |
Why?
| | Insulin | 1 | 1999 | 2170 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 1997 | 2874 | 0.010 |
Why?
| | Injections, Subcutaneous | 1 | 1989 | 139 | 0.010 |
Why?
| | Monitoring, Physiologic | 1 | 1991 | 272 | 0.010 |
Why?
| | Thorax | 1 | 1988 | 45 | 0.010 |
Why?
| | Antigens, Bacterial | 1 | 1989 | 116 | 0.010 |
Why?
| | Sepsis | 1 | 1991 | 531 | 0.000 |
Why?
|
|
Simoes's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|